Cargando…
Rhabdomyosarcoma of the Nasal Cavity: A Case Report
INTRODUCTION: Rhabdomyosarcoma is a high-grade malignant neoplasm with skeletal muscle differentiation; a common soft tissue sarcoma in children but considered one of the rarest in adults. CASE DESCRIPTION: We report a case of 35-year-old male with a chronic productive cough and haemoptysis for five...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348433/ https://www.ncbi.nlm.nih.gov/pubmed/37455686 http://dx.doi.org/10.12890/2023_003926 |
_version_ | 1785073666276458496 |
---|---|
author | Huang, Meiying Deng, Bifan |
author_facet | Huang, Meiying Deng, Bifan |
author_sort | Huang, Meiying |
collection | PubMed |
description | INTRODUCTION: Rhabdomyosarcoma is a high-grade malignant neoplasm with skeletal muscle differentiation; a common soft tissue sarcoma in children but considered one of the rarest in adults. CASE DESCRIPTION: We report a case of 35-year-old male with a chronic productive cough and haemoptysis for five days. A CT scan of the nasopharynx revealed a blocked left maxillary and ethmoid sinus with bone destruction. These findings raised a suspicion of a tumour, and trans-nasal endoscopic sinus surgery was performed. DISCUSSION: Nasal rhabdomyosarcoma is a rare adult malignant tumour. Most patients have lymphatic metastasis or skull base tumour infiltration at the time of the initial diagnosis and treatment, which poses a challenge to the diagnosis and management. CONCLUSION: Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. Therefore, the treatment of rhabdomyosarcoma requires a combination of surgery, chemotherapy, radiotherapy, and immunotherapy to work together to achieve the best care for the patient. LEARNING POINTS: Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. The survival rate of many adult patients with rhabdomyosarcoma is two years or less. The delay in diagnosis and treatment worsens the already low five-year survival rates in adults. |
format | Online Article Text |
id | pubmed-10348433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-103484332023-07-15 Rhabdomyosarcoma of the Nasal Cavity: A Case Report Huang, Meiying Deng, Bifan Eur J Case Rep Intern Med Article INTRODUCTION: Rhabdomyosarcoma is a high-grade malignant neoplasm with skeletal muscle differentiation; a common soft tissue sarcoma in children but considered one of the rarest in adults. CASE DESCRIPTION: We report a case of 35-year-old male with a chronic productive cough and haemoptysis for five days. A CT scan of the nasopharynx revealed a blocked left maxillary and ethmoid sinus with bone destruction. These findings raised a suspicion of a tumour, and trans-nasal endoscopic sinus surgery was performed. DISCUSSION: Nasal rhabdomyosarcoma is a rare adult malignant tumour. Most patients have lymphatic metastasis or skull base tumour infiltration at the time of the initial diagnosis and treatment, which poses a challenge to the diagnosis and management. CONCLUSION: Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. Therefore, the treatment of rhabdomyosarcoma requires a combination of surgery, chemotherapy, radiotherapy, and immunotherapy to work together to achieve the best care for the patient. LEARNING POINTS: Nasal acinar rhabdomyosarcoma, one of the histopathological types of rhabdomyosarcoma, has rapid disease progression and high mortality. The survival rate of many adult patients with rhabdomyosarcoma is two years or less. The delay in diagnosis and treatment worsens the already low five-year survival rates in adults. SMC Media Srl 2023-06-14 /pmc/articles/PMC10348433/ /pubmed/37455686 http://dx.doi.org/10.12890/2023_003926 Text en © EFIM 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Article Huang, Meiying Deng, Bifan Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title | Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title_full | Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title_fullStr | Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title_full_unstemmed | Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title_short | Rhabdomyosarcoma of the Nasal Cavity: A Case Report |
title_sort | rhabdomyosarcoma of the nasal cavity: a case report |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348433/ https://www.ncbi.nlm.nih.gov/pubmed/37455686 http://dx.doi.org/10.12890/2023_003926 |
work_keys_str_mv | AT huangmeiying rhabdomyosarcomaofthenasalcavityacasereport AT dengbifan rhabdomyosarcomaofthenasalcavityacasereport |